Sunmax Biotechnology (Taiwan) Insiders

Sunmax Biotechnology Management Team Effectiveness

The company has return on total asset (ROA) of 0.2825 % which means that it generated a profit of $0.2825 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4759 %, meaning that it generated $0.4759 on every $100 dollars invested by stockholders. Sunmax Biotechnology's management efficiency ratios could be used to measure how well Sunmax Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.

Sunmax Biotechnology Workforce Comparison

The company has Profit Margin (PM) of 0.39 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.56 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.56.

Sunmax Biotechnology Benchmark Summation

The success or failure of an entity such as Sunmax Biotechnology often depends on how effective the management is. Sunmax Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sunmax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sunmax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Sunmax Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sunmax Biotechnology Co. Check Sunmax Biotechnology's Beneish M Score to see the likelihood of Sunmax Biotechnology's management manipulating its earnings.

When running Sunmax Biotechnology's price analysis, check to measure Sunmax Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunmax Biotechnology is operating at the current time. Most of Sunmax Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sunmax Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunmax Biotechnology's price. Additionally, you may evaluate how the addition of Sunmax Biotechnology to your portfolios can decrease your overall portfolio volatility.